About

I am a highly trained neuropharmacologist with over a decade of experience conducting research using rigorous molecular, cellular, and behavioral pharmacology as well as translational complex behavioral assessments in rodent models of neuropsychiatric and neurological disease. My background includes in-depth exploration of the developmental neural mechanisms contributing to cognitive, motivational, and social impairments observed in various brain disorders. Leveraging advanced genetic and pharmacological techniques alongside cutting-edge methodologies like whole-cell patch-clamp electrophysiology, touchscreen-based operant behavior, and in vivo fiber photometry, my aim is to dissect the impact of early life pharmacological exposure on the maturation of prefrontal cortex neurons and circuits. Through this research, my ultimate goal is to develop more targeted and effective pharmacotherapeutics tailored to at-risk populations.